An anaplastic cardiac large cell lymphoma: A case report and
analysis of cardiac involvement in newly diagnosed nonHodgkin’s
lymphoma from the Czech Lymphoma Study Group (CLSG) database

J 2017

An anaplastic cardiac large cell lymphoma: A case report and analysis of cardiac involvement in newly diagnosed nonHodgkin’s lymphoma from the Czech Lymphoma Study Group (CLSG) database

LOBELLO, Cosimo, Andrea JANÍKOVÁ, Leoš KŘEN, Markéta HERMANOVÁ, Andrea ŠPRLÁKOVÁ-PUKOVÁ et. al.

Základní údaje

Originální název

An anaplastic cardiac large cell lymphoma: A case report and analysis of cardiac involvement in newly diagnosed nonHodgkin’s lymphoma from the Czech Lymphoma Study Group (CLSG) database

Autoři

LOBELLO, Cosimo (380 Itálie, domácí), Andrea JANÍKOVÁ (203 Česká republika, domácí), Leoš KŘEN (203 Česká republika, domácí), Markéta HERMANOVÁ (203 Česká republika, domácí), Andrea ŠPRLÁKOVÁ-PUKOVÁ (203 Česká republika), Jan KREJČÍ (203 Česká republika), Šárka POSPÍŠILOVÁ (203 Česká republika, domácí), Robert PYTLÍK (203 Česká republika), Michaela HAMOUZOVÁ (203 Česká republika), David BELADA (203 Česká republika), Vit PROCHAZKA (203 Česká republika), Juraj DURAS (203 Česká republika), Heidi MÓCIKOVÁ (203 Česká republika) a Marek TRNĚNÝ (203 Česká republika)

Vydání

Journal of Cancer Research & Therapy, Manchester, NobleResearch Publishers Limited, 2017, 2052-4994

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Kód RIV

RIV/00216224:14110/17:00099922

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.14312/2052-4994.2017-13

Klíčová slova anglicky

cardiac lymphoma; anaplastic large cell lymphoma; ALK

Štítky

EL OK

Změněno: 6. 3. 2018 15:46, Soňa Böhmová

Anotace

V originále

We report a rare case of anaplastic large cell ALK+ lymphoma (ALCL) with initial asymptomatic cardiac involvement. A 59-year-old male with infiltration of the right ventricular wall underwent standard combined chemotherapy (CHOP) and achieved remission without significant cardiac impairment. Additionally, we report the actual incidence of cardiac lymphoma in newly diagnosed non-Hodgkin Lymphomas (NHLs). In total, 16 patients with cardiac lymphoma were found (0.1% NHLs) in the Czech Lymphoma Study Group database. DLBCL was the most frequent histology subtype (50%), and ALCL was identified in 12.5% of cases. At initial diagnosis, the median age was 55.5 (range 21-74) years and 59% were men. None of the 16 patients with cardiac involvement had isolated heart lymphoma. The response to first-line therapy was 79% in 14/16 evaluable patients. The median progression-free survival and overall survival were nearly the same -approximately 3.5 years (range; 0.05-16.7ys), while the median follow up was 4 years.

Návaznosti

LQ1601, projekt VaV

Název: CEITEC 2020 (Akronym: CEITEC2020)

Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, CEITEC 2020

Citovat

LOBELLO, Cosimo, Andrea JANÍKOVÁ, Leoš KŘEN, Markéta HERMANOVÁ, Andrea ŠPRLÁKOVÁ-PUKOVÁ, Jan KREJČÍ, Šárka POSPÍŠILOVÁ, Robert PYTLÍK, Michaela HAMOUZOVÁ, David BELADA, Vit PROCHAZKA, Juraj DURAS, Heidi MÓCIKOVÁ a Marek TRNĚNÝ. An anaplastic cardiac large cell lymphoma: A case report and analysis of cardiac involvement in newly diagnosed nonHodgkin’s lymphoma from the Czech Lymphoma Study Group (CLSG) database. Journal of Cancer Research & Therapy. Manchester: NobleResearch Publishers Limited, 2017, roč. 5, č. 10, s. 66-71. ISSN 2052-4994. Dostupné z: https://dx.doi.org/10.14312/2052-4994.2017-13.

@article{1407078,
   author = {Lobello, Cosimo and Janíková, Andrea and Křen, Leoš and Hermanová, Markéta and ŠprlákováandPuková, Andrea and Krejčí, Jan and Pospíšilová, Šárka and Pytlík, Robert and Hamouzová, Michaela and Belada, David and Prochazka, Vit and Duras, Juraj and Móciková, Heidi and Trněný, Marek and Janíková, Andrea},
   article_location = {Manchester},
   article_number = {10},
   doi = {http://dx.doi.org/10.14312/2052-4994.2017-13},
   keywords = {cardiac lymphoma; anaplastic large cell lymphoma; ALK},
   language = {eng},
   issn = {2052-4994},
   journal = {Journal of Cancer Research & Therapy},
   title = {An anaplastic cardiac large cell lymphoma: A case report and analysis of cardiac involvement in newly diagnosed nonHodgkin’s lymphoma from the Czech Lymphoma Study Group (CLSG) database},
   url = {http://nobleresearch.org/Doi/10.14312/2052-4994.2017-13},
   volume = {5},
   year = {2017}
}

TY  - JOUR
ID  - 1407078
AU  - Lobello, Cosimo - Janíková, Andrea - Křen, Leoš - Hermanová, Markéta - Šprláková-Puková, Andrea - Krejčí, Jan - Pospíšilová, Šárka - Pytlík, Robert - Hamouzová, Michaela - Belada, David - Prochazka, Vit - Duras, Juraj - Móciková, Heidi - Trněný, Marek - Janíková, Andrea
PY  - 2017
TI  - An anaplastic cardiac large cell lymphoma: A case report and analysis of cardiac involvement in newly diagnosed nonHodgkin’s lymphoma from the Czech Lymphoma Study Group (CLSG) database
JF  - Journal of Cancer Research & Therapy
VL  - 5
IS  - 10
SP  - 66-71
EP  - 66-71
PB  - NobleResearch Publishers Limited
SN  - 20524994
KW  - cardiac lymphoma
KW  - anaplastic large cell lymphoma
KW  - ALK
UR  - http://nobleresearch.org/Doi/10.14312/2052-4994.2017-13
N2  - We report a rare case of anaplastic large cell ALK+ lymphoma (ALCL) with initial asymptomatic cardiac involvement. A 59-year-old male with infiltration of the right ventricular wall underwent standard combined chemotherapy (CHOP) and achieved remission without significant cardiac impairment. Additionally, we report the actual incidence of cardiac lymphoma in newly diagnosed non-Hodgkin Lymphomas (NHLs). In total, 16 patients with cardiac lymphoma were found (0.1% NHLs) in the Czech Lymphoma Study Group database. DLBCL was the most frequent histology subtype (50%), and ALCL was identified in 12.5% of cases. At initial diagnosis, the median age was 55.5 (range 21-74) years and 59% were men. None of the 16 patients with cardiac involvement had isolated heart lymphoma. The response to first-line therapy was 79% in 14/16 evaluable patients. The median progression-free survival and overall survival were nearly the same -approximately 3.5 years (range; 0.05-16.7ys), while the median follow up was 4 years.
ER  -

LOBELLO, Cosimo, Andrea JANÍKOVÁ, Leoš KŘEN, Markéta HERMANOVÁ, Andrea ŠPRLÁKOVÁ-PUKOVÁ, Jan KREJČÍ, Šárka POSPÍŠILOVÁ, Robert PYTLÍK, Michaela HAMOUZOVÁ, David BELADA, Vit PROCHAZKA, Juraj DURAS, Heidi MÓCIKOVÁ a Marek TRNĚNÝ. An anaplastic cardiac large cell lymphoma: A case report and analysis of cardiac involvement in newly diagnosed nonHodgkin’s lymphoma from the Czech Lymphoma Study Group (CLSG) database. \textit{Journal of Cancer Research \&{} Therapy}. Manchester: NobleResearch Publishers Limited, 2017, roč.~5, č.~10, s.~66-71. ISSN~2052-4994. Dostupné z: https://dx.doi.org/10.14312/2052-4994.2017-13.

Podrobný výpis o publikaci